BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25539984)

  • 21. The chorioallantoic membrane assay is a promising ex vivo model system for the study of vascular anomalies.
    Jedelská J; Strehlow B; Bakowsky U; Aigner A; Höbel S; Bette M; Roessler M; Franke N; Teymoortash A; Werner JA; Eivazi B; Mandic R
    In Vivo; 2013; 27(6):701-5. PubMed ID: 24292571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cell death in rat brain by a gliotoxic factor from cerebrospinal fluid in multiple sclerosis.
    Benjelloun N; Charriaut-Marlangue C; Hantaz-Ambroise D; Ménard A; Pierig R; Alliel PM; Rieger F
    Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):205-12. PubMed ID: 11990457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of angiogenic and anti-angiogenic molecules in the chick embryo chorioallantoic membrane and selected organs during embryonic development.
    Marinaccio C; Nico B; Ribatti D
    Int J Dev Biol; 2013; 57(11-12):907-16. PubMed ID: 24623083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.
    Ribatti D
    Int Rev Cell Mol Biol; 2008; 270():181-224. PubMed ID: 19081537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord.
    Scalabrino G; Veber D; De Giuseppe R; Roncaroli F
    Neuroscience; 2015 Jul; 298():293-301. PubMed ID: 25888933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
    Rot U; Ledinek AH; Jazbec SS
    Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
    Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
    Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
    van Luijn MM; van Meurs M; Stoop MP; Verbraak E; Wierenga-Wolf AF; Melief MJ; Kreft KL; Verdijk RM; 't Hart BA; Luider TM; Laman JD; Hintzen RQ
    J Neuropathol Exp Neurol; 2016 Jan; 75(1):86-98. PubMed ID: 26683597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.
    Contini C; Cultrera R; Seraceni S; Castellazzi M; Granieri E; Fainardi E
    Mult Scler; 2004 Aug; 10(4):360-9. PubMed ID: 15327030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid cytologic findings in multiple sclerosis. A comparison between patient subgroups.
    Zeman D; Adam P; Kalistová H; Sobek O; Andĕl J; Andĕl M
    Acta Cytol; 2001; 45(1):51-9. PubMed ID: 11213505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo angiogenic activity of erythropoietin.
    Ribatti D
    Methods Mol Biol; 2013; 982():227-35. PubMed ID: 23456873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.
    Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I
    Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
    Jasperse B; Jakobs C; Eikelenboom MJ; Dijkstra CD; Uitdehaag BM; Barkhof F; Polman CH; Teunissen CE
    J Neurol; 2007 May; 254(5):631-7. PubMed ID: 17415509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.